-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-intro-methods-cx061721.pdf
December 01, 2020 - National Tuberculosis Surveillance System (NTSS)
• National Vital Statistics System—Linked Birth and Infant
-
effectivehealthcare.ahrq.gov/health-topics/childhood-brain-tumors
-
effectivehealthcare.ahrq.gov/health-topics/vitamin-d/
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
January 01, 2019 - funded by the Centers for Disease Control and Prevention, which aims to improve
outcomes for women and infants … USPSTF recommends that primary care clinicians apply fluoride varnish to the
primary teeth of all infants
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KYaqKCUyn2rjUGfoS977h8
July 10, 2023 - In
the trial of cisgender women, no congenital abnormalities were
observed in infants of those who … for PrEP during pregnancy is very sparse, al-
though 1 trial7 reported no congenital abnormalities in infants
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - Women and Infants’ Hospital of Rhode Island
Providence, RI
John Wei, M.D., M.S. … Women and Infants’ Hospital of Rhode Island
Providence, RI
John Wei, M.D., M.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - Women and Infants’ Hospital of Rhode Island
Providence, RI
John Wei, M.D., M.S. … Women and Infants’ Hospital of Rhode Island
Providence, RI
John Wei, M.D., M.S.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KFZpoMBYuoo8TRW6nhRev8
October 23, 2023 - In the trial
of cisgender women, no congenital abnormalities were observed in
infants of those who became … for PrEP during pregnancy is very sparse, al-
though 1 trial7 reported no congenital abnormalities in infants
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - inhibitors"[tw] OR "DRI"[tw]
OR "DRIs"[tw]
53191
#4 AND (English[lang] AND systematic[sb] NOT ("infant … "[MeSH Terms] OR
("infant"[MeSH Terms] OR "child"[MeSH Terms] OR "adolescent"[MeSH Terms] OR
("animals
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - inhibitors"[tw] OR "DRI"[tw]
OR "DRIs"[tw]
53191
#4 AND (English[lang] AND systematic[sb] NOT ("infant … "[MeSH Terms] OR
("infant"[MeSH Terms] OR "child"[MeSH Terms] OR "adolescent"[MeSH Terms] OR
("animals
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - [ti] OR babies[ti] OR baby[ti] OR boy[ti] OR boys[ti] OR
child*[ti] OR girl*[ti] OR infancy[ti] OR infant … [ti] OR babies[ti] OR baby[ti] OR boy[ti] OR boys[ti] OR child*[ti] OR
girl*[ti] OR infancy[ti] OR infant
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-248-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
March 01, 2018 - Population – infants (29 days to 1 year) (specify age range): Yes; 90-364 days.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
March 01, 2018 - Population – infants (29 days to 1 year) (specify age range): Yes; 90-364 days.
q.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
March 01, 2018 - Population – infants (29 days to 1 year) (specify age range): Yes; 90-364 days.
q.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
March 01, 2018 - Population – infants (29 days to 1 year) (specify age range): Yes; 90-364 days.
q.